ConductScience.org, home

Paper36940609

The protein disulfide isomerase inhibitor 3-methyltoxoflavin inhibits Chikungunya virus.

Puhl AC and 5 others. Bioorg Med Chem, 2023. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. The protein disulfide isomerase inhibitor 3-methyltoxoflavin inhibits Chikungunya virus. Papers, record 36940609. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36940609

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The protein disulfide isomerase inhibitor 3-methyltoxoflavin inhibits Chikungunya virus.
PubMed
Journal
Bioorg Med Chem
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.85
iCite
Revised in PubMed
2024-04-02
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Puhl ACAna C
2Fernandes RSRafaela S
3Godoy ASAndre S
4Gil LHVGLaura H V G
5Oliva GGlaucius
6Ekins SSean

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Chikungunya FeverMajor topic
Chikungunya virusMajor topic
Animals
Humans
Mice
Antiviral Agents
Caco-2 Cells
Protein Disulfide-Isomerases
Virus Replication
Flavins

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
K05 AT001585NCCIH NIH HHSUnited StatesK05AT001585PubMedNIH RePORTER
R43 AT010585NCCIH NIH HHSUnited StatesR43AT010585PubMed and NIHNIH RePORTER
R44 GM122196NIGMS NIH HHSUnited StatesR44GM122196PubMed and NIHNIH RePORTER

Download CSV of grants

References61

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134056242Novel Analogues of the Chikungunya Virus Protease Inhibitor: Molecular Design, Synthesis, and Biological Evaluation.ACS Omega2021https://conductscience.org/library/papers/34056242PubMed
222988091Discovery of an orally active small-molecule irreversible inhibitor of protein disulfide isomerase for ovarian cancer treatment.Proc Natl Acad Sci U S A2012https://conductscience.org/library/papers/22988091PubMed
336269563Machine Learning Models Identify New Inhibitors for Human OATP1B1.Mol Pharm2022https://conductscience.org/library/papers/36269563PubMed
432928738Small-Molecule Inhibitors of Chikungunya Virus: Mechanisms of Action and Antiviral Drug Resistance.Antimicrob Agents Chemother2020https://conductscience.org/library/papers/32928738PubMed
621121641Discovery of a small molecule PDI inhibitor that inhibits reduction of HIV-1 envelope glycoprotein gp120.ACS Chem Biol2011https://conductscience.org/library/papers/21121641PubMed
723403423A reprofiled drug, auranofin, is effective against metronidazole-resistant Giardia lamblia.Antimicrob Agents Chemother2013https://conductscience.org/library/papers/23403423PubMed
833835811Targeting Chikungunya Virus Replication by Benzoannulene Inhibitors.J Med Chem2021https://conductscience.org/library/papers/33835811PubMed
928288924Global expansion of chikungunya virus: mapping the 64-year history.Int J Infect Dis2017https://conductscience.org/library/papers/28288924PubMed
1019559054Assay development and high-throughput antiviral drug screening against Bluetongue virus.Antiviral Res2009https://conductscience.org/library/papers/19559054PubMed
1136239304Discovery of New Zika Protease and Polymerase Inhibitors through the Open Science Collaboration Project OpenZika.J Chem Inf Model2022https://conductscience.org/library/papers/36239304PubMed
1226159730Chikungunya virus pathogenesis: From bedside to bench.Antiviral Res2015https://conductscience.org/library/papers/26159730PubMed
1335301150Redox active or thiol reactive? Optimization of rapid screens to identify less evident nuisance compounds.Drug Discov Today2022https://conductscience.org/library/papers/35301150PubMed
1432340991Novel Class of Chikungunya Virus Small Molecule Inhibitors That Targets the Viral Capping Machinery.Antimicrob Agents Chemother2020https://conductscience.org/library/papers/32340991PubMed
1523151166Chikungunya virus and prospects for a vaccine.Expert Rev Vaccines2012https://conductscience.org/library/papers/23151166PubMed
1631751347Repurposing the antimalarial pyronaridine tetraphosphate to protect against Ebola virus infection.PLoS Negl Trop Dis2019https://conductscience.org/library/papers/31751347PubMed
1729454041Potential risks of Zika and chikungunya outbreaks in Brazil: A modeling study.Int J Infect Dis2018https://conductscience.org/library/papers/29454041PubMed
1835891332The Antifungal Itraconazole Is a Potent Inhibitor of Chikungunya Virus Replication.Viruses2022https://conductscience.org/library/papers/35891332PubMed
1928461071Host oxidative folding pathways offer novel anti-chikungunya virus drug targets with broad spectrum potential.Antiviral Res2017https://conductscience.org/library/papers/28461071PubMed
2034964633Machine Learning Models for Mycobacterium tuberculosisIn Vitro Activity: Prediction and Target Visualization.Mol Pharm2022https://conductscience.org/library/papers/34964633PubMed
2134372513Antivirals against the Chikungunya Virus.Viruses2021https://conductscience.org/library/papers/34372513PubMed

See all 61 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
42787651Workflow for Accurate Measurement of PDI Reductase Kinetics Using a Fluorescent Disulfide Substrate.MicroPubl Biol2026https://conductscience.org/library/papers/42787651PubMed
42368589Recent advances in antiviral drugs for Chikungunya virus (CHIKV): Targets, mechanisms, and development strategies.Acta Pharm Sin B2026https://conductscience.org/library/papers/42368589PubMed
40007016Neuropathogenesis of Old World Alphaviruses: Considerations for the Development of Medical Countermeasures.Viruses2025https://conductscience.org/library/papers/40007016PubMed
39193780Pathogenicity and virulence of chikungunya virus.Virulence2024https://conductscience.org/library/papers/39193780PubMed
38910486Advances in the Development of Non-Structural Protein 1 (NsP1) Inhibitors for the Treatment of Chikungunya Virus Infection.Mini Rev Med Chem2024https://conductscience.org/library/papers/38910486PubMed
37482237Learning from COVID-19: How drug hunters can prepare for the next pandemic.Drug Discov Today2023https://conductscience.org/library/papers/37482237PubMed

Download CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36940609

GET https://conductscience.org/api/papers/v1/36940609/references?page=2